Montserrat Vendrell

Director/Board Member at ORYZON GENOMICS S.A.

Health Technology

Consumer Services

Finance

Profile

Montserrat Vendrell is an Independent Director at Oryzon Genomics SA since 2025.
Director at Ona Therapeutics SL and Inbrain Neuroelectronics SL.
Board Member at Peptomyc SL since 2017.
Partner at Asabys Partners SGEIC SA since 2025.
Formerly Chairman at Accure Therapeutics SL.
Managing Partner at Altamar Private Equity SGIIC SA from 2016 to 2025.
Education includes a doctorate from the University of Barcelona in 1987, a graduate degree from Universitat Pompeu Fabra in 1997, and a graduate degree from the University of Navarra in 2007.

Montserrat Vendrell active positions

Companies	Position	Start
ORYZON GENOMICS S.A.	Director/Board Member	28/02/2025
Peptomyc SL Peptomyc SL Pharmaceuticals: MajorHealth Technology Develops cell penetrating peptides targeting the Myc oncoprotein for cancer treatment	Director/Board Member	01/07/2017
Ona Therapeutics SL Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases	Director/Board Member	-
Inbrain Neuroelectronics SL Inbrain Neuroelectronics SL Medical SpecialtiesHealth Technology Operates as a medical device company that develops graphene neural interfaces and neuromodulation systems	Director/Board Member	-
Asabys Partners SGEIC SA Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners invests in companies located in Spain, Europe, Israel, Switzerland and the United Kingdom. The firm targets companies operating in the fields of biotechnology, disruptive services, medical devices, health technologies, medTech and digital health. It provides financing for early stage capital requirements with investment size ranging from EUR 3 million.	Private Equity Investor	01/10/2025

All active positions of Montserrat Vendrell

Former positions of Montserrat Vendrell

Companies	Position	End
Altamar Private Equity SGIIC SA /Private Equity/ Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments.	Private Equity Investor	01/10/2025
Accure Therapeutics SL Accure Therapeutics SL Pharmaceuticals: MajorHealth Technology Develops medicines to treat patient suffering from central nervous system	Chairman	-

See the detail of Montserrat Vendrell's experience

Training of Montserrat Vendrell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Montserrat Vendrell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Oryzon Genomics SA Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics	Health Technology
University of Barcelona University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Navarra University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Universitat Pompeu Fabra Universitat Pompeu Fabra Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Altamar Private Equity SGIIC SA /Private Equity/ Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments.	Finance
Peptomyc SL Peptomyc SL Pharmaceuticals: MajorHealth Technology Develops cell penetrating peptides targeting the Myc oncoprotein for cancer treatment	Health Technology
Asabys Partners SGEIC SA Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners invests in companies located in Spain, Europe, Israel, Switzerland and the United Kingdom. The firm targets companies operating in the fields of biotechnology, disruptive services, medical devices, health technologies, medTech and digital health. It provides financing for early stage capital requirements with investment size ranging from EUR 3 million.	Finance
Ona Therapeutics SL Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases	Health Technology
Accure Therapeutics SL Accure Therapeutics SL Pharmaceuticals: MajorHealth Technology Develops medicines to treat patient suffering from central nervous system	Health Technology
Inbrain Neuroelectronics SL Inbrain Neuroelectronics SL Medical SpecialtiesHealth Technology Operates as a medical device company that develops graphene neural interfaces and neuromodulation systems	Health Technology